Mostrar o rexistro simple do ítem

Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer

dc.contributor.authorAntolín Novoa, Silvia 
dc.date.accessioned2017-06-07T07:36:54Z
dc.date.available2017-06-07T07:36:54Z
dc.date.issued2014
dc.identifier.issn0959-8049
dc.identifier.urihttp://hdl.handle.net/20.500.11940/8526
dc.language.isoeng
dc.titlePhase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer
dc.typePublicación de congreso
dc.authorsophosGil, M.
dc.authorsophosMartin, M.
dc.authorsophosAntolin, S.
dc.authorsophosTrigo, J. M.
dc.authorsophosGuerrero, A.
dc.authorsophosVidal, L.
dc.authorsophosUrruticoechea, A.
dc.authorsophosPandiella, A.
dc.authorsophosHernando, A.
dc.authorsophosOcana, A.
dc.identifier.sophos15383
dc.issue.numberS
dc.journal.titleEUROPEAN JOURNAL OF CANCER
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initialS180
dc.page.finalS180
dc.rights.accessRightsopenAccess
dc.typesophosComunicaciones a congresos
dc.volume.number50


Ficheiros no ítem

FicheirosTamañoFormatoVer

Non hai ficheiros asociados a este ítem.

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem